ホーム601607 • SHA
add
Shanghai Pharmaceuticals Holding Ord Shs A
前日の終値
¥20.07
日次変動幅
¥19.82 - ¥20.07
年間変動幅
¥15.36 - ¥23.20
時価総額
661.08億 CNY
平均取引高
1187.13万
株価収益率
18.32
配当利回り
1.43%
優先市場
SHA
市場ニュース
財務情報
損益計算書
収益
純利益
(CNY) | 2024年9月info | 前年比変化率 |
---|---|---|
収益 | 702.16億 | 8.16% |
営業費用 | 43.06億 | -4.78% |
純利益 | 11.12億 | -6.29% |
純利益率 | 1.58 | -13.66% |
1 株当たりの収益 | — | — |
EBITDA | 31.28億 | 15.99% |
実効税率 | 21.75% | — |
貸借対照表
総資産
負債総額
(CNY) | 2024年9月info | 前年比変化率 |
---|---|---|
現金および短期投資 | 423.85億 | 4.22% |
総資産 | 2237.41億 | 4.97% |
負債総額 | 1405.84億 | 5.70% |
純資産 | 831.58億 | — |
発行済み株式 | 37.52億 | — |
帳簿価格 | 1.06 | — |
総資産利益率 | 3.14% | — |
資本利益率 | 5.13% | — |
キャッシュ フロー
現金の純増減額
(CNY) | 2024年9月info | 前年比変化率 |
---|---|---|
純利益 | 11.12億 | -6.29% |
営業キャッシュ フロー | 22.68億 | 241.50% |
投資キャッシュ フロー | -16.75億 | -335.23% |
財務キャッシュ フロー | -36.26億 | -55.26% |
現金の純増減額 | -30.49億 | -44.04% |
フリー キャッシュ フロー | 38.21億 | 177.98% |
概要
Shanghai Pharmaceuticals is a Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of year 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
設立
1994/01/18
ウェブサイト
従業員数
49,234